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Abstract
Aflatoxin B1 (AFB1) is an important environmental carcinogen for the development of 
hepatocellular carcinoma (HCC). HCC is a complex disease likely resulting from genetic 
single nucleotide polymorphisms (GSNPs) of multiple interacting genes and gene-
environment interactions. Recent efforts have been made to analyze the associations 
between risk of this malignancy and GSNPs in genes involved in the repair of DNA 
damage induced by AFB1. Here, we reviewed the results of published case-control stud-
ies that have examined the effects of common alleles of all susceptible DNA repair genes, 
including XRCC1, XRCC3, XRCC4, XRCC7, XPC, and XPD, on risk of AFB1-related HCC 
among Guangxi population. Statistically significant differences in genotype frequen-
cies found in case-control comparisons were rs25487, rs80309960, rs861539, rs7003908, 
rs28383151, rs3734091, rs13181, and rs2228001 polymorphism. The overall effects of 
these GNSPs were moderate in terms of relative risk, with ORs ranging from 2 to 10. 
Furthermore, some evidence of the interaction of GSNPs in DNA repair genes and AFB1 
exposure modulate risk of this cancer was also found, although the results require con-
firmation with larger sample size studies.
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1. Introduction
In China, hepatocellular carcinoma (HCC) is the fourth most common malignant tumors 
and accounts for about 50% of the world’s HCC cases [1, 2]. This malignancy occurs more 
often in some hot and humid areas such as Guangxi area, mainly because of high aflatoxin 
B1(AFB1) exposure [3, 4]. However, accumulating epidemiological evidence has shown that 
although many people are exposed to this risk factor, only a relatively small proportion of 
people with chronic AFB1 exposure develop HCC [3, 4]. This suggests that an individual 
susceptibility related to genetic factors including genetic single nucleotide polymorphisms 
(GSNPs) in DNA repair genes might be correlated with HCC tumorigenesis [3–5]. In past 
several decade years, evidence has been accumulated to support the hypothesis that GSNPs 
in DNA repair genes may be of importance in determining individual susceptibility to AFB1-
related HCC [6–8]. Here, we review recent efforts in identifying genetic single nucleotide 
polymorphisms (SNPs) in DNA repair genes, which may have impact on AFB1-related HCC 
risk among Guangxiese population.
2. Epidemiology of AFB1-related HCC among Guangxi areas
In Guangxi, a known high AFB1 exposure area, HCC is the most common occurring cancer [5]. 
Epidemiologically, this type tumor is characterized as follows: (a) the incidence rate display-
ing a noticeable mountain shape, gradually increasing with age increasing before shape top 
and gradually decreasing with age increasing after shape top and (b) more than three times 
risk of HCC among males than among females, especially in the high AFB1-exposure areas 
(including Baise and Nanning) [5]. During 1990–1992, the incidence rates of this tumor in 
Guangxi area increased markedly compared between the late 1970s and the early 1980s (25.22 
per 100,000 vs. 15.85 per 100,000), especially male Guangxiese population (Figure 1A) [9]. This 
might result from the increasing infective rate of hepatitis viruses and advance of diagnostic 
ability [10]. The following epidemiological investigations showed that the incidence rate of 
HCC among Guangxiese population significantly markedly decrease during 2004 and 2005 
(mainly because of the control of hepatitis virus infection) (Figure 1) [9]. However, the incident 
rates of this tumor in high AFB1-exposure areas have little change. According to epidemio-
logical investigation from AFB1-exposures areas, during May 2007–April 2008, incidence rates 
were 103.1/100,000 and 117.8/100,000 for Fusui in Nanning and Xiangzhou in Baise (two main 
high AFB1 exposure areas), respectively [11]. This is similar to the results before 10 years [11].
Because of the very poor prognosis, HCC is the first most common cause of death from can-
cer in Guangxi [9]. In the past 40 years, the total mortality rate of HCC gradually increased 
and followed by gradually decreased (Figure 1B), regardless of male or female population. 
Furthermore, this trend was not only associated with age but also more noticeable in male 
population than female population (Figure 2), possibly because male individuals featured 
more AFB1 exposure [4]. Supporting above-mentioned hypothesis, molecular epidemiologi-
cal studies from high AFB1-exposure areas of Guangxi have exhibited that these individu-
als featuring more AFB1 exposure would face decreasing 5-year survival rate and increasing 
death risk [12–14].
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3. DNA damage induced byAFB1 and DNA repair
Several previous reviews have significantly summarized the toxicology of AFB1 [3–5, 15]. 
Generally, AFB1, an important mycotoxin and a category I known human carcinogen pro-
duced by Aspergillus parasiticus and Aspergillus flavus [4, 5], has been found as toxic contami-
nants of human food such as ground nuts and core in tropical areas as a result of fungal 
contamination during growth and after harvest which under hot and humid conditions 
[15]. Once this toxigenic agent is taken into body, it is metabolized by phase I detoxification 
enzymes to its reactive form, also called AFB1-8,9-epoxide (AFBO). This reactive product can 
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Figure 1. The incidence and mortality rates of hepatocellular carcinoma (HCC) in Guangxi during 1971 and 2005. Total 
incidence rate (A) and mortality rates (B), regardless of male or female population, were significantly increasing from 
during 1971 and 1973 to during 1990 and 1992. However, they would decrease during 2004 and 2005.
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Figure 2. The gender and age distributions of hepatocellular carcinoma (HCC) mortality among Guangxiese population. 
(A) The gender and age distributions of HCC mortality between 1990 and 1992. (B) The gender and age distributions of 
HCC mortality between 2004 and 2005.
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also covalently bind to DNA and induce DNA damage, which might ultimately result to the 
development of HCC [16, 17].
AFB1-induced DNA damage types consist of DNA adducts, oxidative damage, and gene muta-
tions. For AFB1-DNA adducts, AFB1-N7-Gua adduct, the most common adduct type, is primarily 
identified and confirmed in vivo research studies [17–22], whereas the formamidopyridine AFB1 
adduct (AFB1-FAPy) is a ring-opened DNA adduct [23, 24]. Because of the accumulations of 
AFB1-FAPy, it is characterized by a time-dependent and non-enzyme way and exhibits apparent 
persistence in DNA; it may be of biological basis of genes mutation. Furthermore, AFB1-N7-Gua 
and AFB1-FAPy can induce error-prone DNA repair and result in the damage of DNA strands, 
including double-strand breaks (DSBs), single-strand breaks (SSBs), base pair substitution, frame 
shift mutations, and oxidation DNA damage such as 8-oxodeoxyguanosine (8-oxyG) [25–28]. For 
genes mutations induced by AFB1 exposure, G:C > T:A mutation in codon 249 of TP53 gene has 
been frequently reported [29–36]. This mutation is tested in more than 40% of HCC from high-
AFB1-exposure areas, but in either very rare or absent for those from low or null AFB1 exposure 
areas [36–39]. Therefore, G:C > T:A mutation in codon 249 of TP53 gene is regarded as the hotspot 
mutation caused by AFB1 and the molecular symbol of AFB1-related HCC [40–42].
DNA damage by AFB1 exposure, if not repaired, may cause genomic instability and ulti-
mately result in cellular malignant transformation and tumor formation [20]. In human cells, 
several evolved surveillance mechanisms, including base excision repair (BER), nucleotide 
excision repair (NER), single-strand break repair (SSBR), and double-strand break repair 
(DSBR), can monitor the integrity of genome and repair and minimize the consequences of 
detrimental genome damage [3, 40]. DNA repair genes play an important role during afore-
mentioned repair pathways of DNA damage; therefore, GSNPs in the DNA repair genes may 
be associated with risk of developing AFB1-related HCC [4].
4. Xeroderma pigmentosum C (XPC) GSNPs and AFB1-HCC among 
Guangxiese population
Xeroderma pigmentosum C (XPC) gene locates on chromosome 3p25 and spans 33kb. Its 
encoding protein consists of 940 amino acids and acts as a DNA damage recognition mol-
ecule during the global genome NER pathway [43, 44]. XPC can bind tightly with RAD23 
homolog B (RAD23B, also called HR23B) to form a stable XPC/RAD23B complex. This com-
plex can recognize DNA adducts formed by exogenous carcinogens such as AFB1 and 
binds to the DNA damage sites [44]. Thus, XPC may play a role in the pathogenesis of 
HCC-related AFB1. The pathological and cellular researches have shown that the abnormal 
expression of this gene is correlated with hepatocarcinogenesis [45]. Some studies have 
shown that GSNPs of XPC (rs2228001 (also called codon Lys939Gln polymorphism) can 
decrease DNA repair capacity related to AFB1-induced DNA damage [46–49]. In the past 
several decade years, a total of four studies from Guangxi area reported XPC rs2228001 
polymorphism was involved in AFB1 detoxification (Table 1) [12, 49–51]. The first study 
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conducted by Wu et al. [51] is from Baise area (a famous high AFB1 exposure area with high 
incidence rate of HCC). In this study, researchers investigated the association between XPC 
rs2228001 polymorphism and HCC risk via an hospital-based case-control study (includ-
ing 98 HCC patients and 157 age-, sex-, race-, and hepatitis viruses-matching controls) 
method and found XPC rs2228001 polymorphism increased HCC risk of female individu-
als (odds ratios [ORs] were 5.44 with 95% CI 1.38–21.50), but not tumor risk of male popu-
lation. Noticeably, they found a significant interaction of XPC variables and AFB1 exposure 
levels [51].
Results from the matching-design studies with large-size samples show that the mutant geno-
types of XPC rs2228001 polymorphism increased about two times risk of HCC [12, 49]. The fol-
lowing quantitative analysis exhibited that AFB1 exposure interacted with risk genotypes of XPC 
rs2228001 polymorphism on HCC risk (22.33 > 1.88 × 8.69 for the interaction of AFB1-exposure 
years and XPC risk genotypes and 18.38 > 1.11 × 4.62 for the interaction of AFB1-exposure levels 
and XPC risk genotypes) [12, 49]. Furthermore, mutant alleles were correlated with the decrease 
of XPC expression levels in cancerous tissues and with the overall survival of HCC patients [12]. 
However, another study also from Nanning area (another high AFB1 exposure area in Guangxi) 
exhibited that this polymorphism does not change HCC risk [50], possibly because it bases on 
nonmatching design and some confounders might affect their results. Interestingly, a significant 
risk value for HCC among female population was observed in the stratified analyses (OR = 2.17, 
95% CI = 1.01–4.64), similar with findings from Wu et al. [51]. Given these different effects, we 
accomplished meta-analysis and found XPC rs2228001 polymorphism increased AFB1-related 
risk (combined OR = 1.89, P < 0.01). Therefore, these results demonstrate that GSNP at codon 
939 of XPC gene is not only a genetic determinant in the development of HCC caused by AFB1 
No. Ref. Year AFB1 
exposurea
Methods Matching  
factor
Cases Controls Risk valueb
(n) (n) (OR)
1 Wu et al. [51] 2010 High Case-control Age, sex, 
HBV, HCV, 
race
98 157 1.46–2.08 
(P < 0.05)
2 Long et al. [12] 2010 High Case-control Age, sex, 
HBV, HCV, 
race
1156 1402 1.25–1.81 
(P < 0.001)
3 Li et al. [50] 2010 High Case-control No 500 507 1.20–1.81 
(P > 0.05)
4 Yao et al. [49] 2014 High Case-control Age, sex, 
HBV, HCV, 
race
1486 1996 1.57–2.19 
(P < 0.001)
aDefined by means of Henry et al. (Science, 1999).
b AFB1-related HCC risk will increase if OR > 1 and corresponding P-value < 0.05; will decrease if OR < 1 and corresponding 
P-value < 0.05; and will not change if OR is about 1 and/or corresponding P-value > 0.05.
Table 1. Characteristics of studies about GSNP at codon 939 of XPC and AFB1-related HCC risk.
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in Guangxiese population but also an independent prognostic factor influencing the survival of 
HCC, like AFB1 exposure.
5. Xeroderma pigmentosum D (XPD) GSNPs and AFB1-HCC among 
Guangxiese population
Xeroderma pigmentosum gene, contains 22 introns and 23 exons, locates on 19q13.3 and 
spans about 20 kb [3, 52]. Its encoded product is one of the TFIIH complexes (a DNA-
dependent ATPase/helicase complex), it has classically been linked to the damage verifi-
cation and the opening of the DNA helix step of NER pathway [53]. To date, molecular 
epidemiological studies on two GSNPs in this gene, namely, rs369191500 polymorphism 
(codon 312, Asp to Asn) and rs13181 polymorphism (codon 751, Lys to Gln), have been con-
ducted by different laboratories [54]. Genotype-phenotype analyses have shown that these 
two GSNPs are associated with low DNA repair ability, which might modify DNA-adduct 
levels, p53 gene mutation, and risk of cancer [55, 56]. For genetic polymorphisms among 
Guangxiese population, a total of four epidemiological studies have been conducted via 
case-control design (Table 2). In 2009, Zeng et al. [57] investigated the association between 
XPD GSNPs and HCC and observed about 2.60-time risk of HCC for these with mutant 
genotypes of XPD codon 751. After that, results from Long et al. [58] and Yao et al. [49] have 
exhibited that the variants of XPD rs13181 polymorphism (including rs13181-LG and -GG) 
was significantly different between controls and HCC cases (26.3 vs. 35.9% for rs13181-LG 
and 8.6 vs. 20.1% for rs13181-GG, respectively, P < 0.001). Mutant alleles increased the 
No. Ref. Year AFB1 
exposurea
Methods Matching 
factor
Cases Controls Risk valueb
(n) (n) (OR)
1 Zeng et al. [57] 2009 High Case-
control
No 300 312 About 2.60 
(P < 0.001)
2 Long et al. [58] 2009 High Case-
control
Age, sex, 
HBV, HCV, 
race
618 712 1.75–2.47 
(P < 0.001)
3 Yao et al. [49] 2014 High Case-
control
Age, sex, 
HBV, HCV, 
race
1486 1996 2.19–4.27 
(P < 0.001)
4 Hu et al. [59] 2016 High Case-
control
No 178 178 2.33–3.38 
(P < 0.05)
a Defined by means of Henry et al. (Science, 1999).
b AFB1-related HCC risk will increase if OR > 1 and corresponding P-value < 0.05; will decrease if OR < 1 and corresponding 
P-value < 0.05; and will not change if OR is about 1 and/or corresponding P-value > 0.05.
Table 2. Characteristics of studies about genetic polymorphism at codon 751 of XPD and AFB1-related HCC risk.
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risk of developing the cancer with a risk value of 1.75 (1.30–2.37) for Lys/Gln and 2.47 
(1.62–3.76) for Gln/Gln, respectively [58]. Furthermore, the interactive effects of mutant 
genotypes of rs13181 polymorphism in XPD gene and AFB1 exposure on HCC risk were 
also found (Pinteraction < 0.05) [49]. Recently, Hu et al. [59] have reported higher frequency of XPD codon 751 Gln alleles among HCC families than among non-HCC families. This sug-
gests that genetic susceptibility resulting from XPD GSNPs might have a potential effect 
on AFB1-related HCC risk among Guangxiese population. Meta-analysis further improved 
the above-mentioned hypothesis [56]. However, the studies from molecular epidemiologi-
cal studies exhibit that another GSNP of XPD is not significantly correlate with the risk of 
HCC related to AFB1 [49, 58].
6. The human 8-oxoguanine DNA glycosylase (hOGG1) GSNPs and 
AFB1-HCC among Guangxiese population
As described previously [60], DNA glycosylases play a central role in the BER pathway 
because they can recognize and catalyze the removal of damaged bases. Among having 
been reported GSNPs in DNA glycosylase-encoded genes, only hOGG1 correlates with 
DNA repair capacity [5, 61]. This gene consists of 7 exons and 6 introns and spans 17 kb on 
chromosome 3p26.2. It encodes a 546-amino acid protein, a specific DNA glycosylase that 
catalyzes the release of 8-oxyG and the cleavage of DNA at the AP site (Figure 3) [61, 62]. The presence of several polymorphisms within hOGG1 locus is identified and only rs1052133 
polymorphism (at codon 326, Ser → Cys) is suggested to modify DNA repair capacity [63–
65]. Therefore, low capacity of 8-oxyG repair resulting from hOGG1 326Cys polymorphism might contribute to the persistence of 8-oxyG in genomic DNA in vivo, which, in turn, could be associated with increased cancer risk [66]. Several reports imply this polymorphism 
may be associated with HCC related to AFB1 exposure [67–70]. Through a hospital-based 
case-control study (including 500 cases with HCC and 507 healthy controls) conducted in 
Nanning area from Guangxi, Ji et al. [67] investigated the relationship between hOGG1 
rs1052133 polymorphism and HCC risk and found significantly different distribution of 
three genotypes (Ser/Ser, Ser/Cys, and Cys/Cys) between cases and controls (71.40, 8.00, and 
20.60% for patients with HCC, 84.22, 10.06, and 5.72% for controls). Regression logistic anal-
ysis shows that mutant alleles of this polymorphism increase AFB1-related HCC risk (OR 
= 2.14, 95% CI = 1.57–2.91). Molecular epidemiological studies from other researchers have 
also proved higher frequencies of Cys alleles in HCC cases than controls and this change 
increased HCC risk among Guangxiese population featuring AFB1-exposure history [69, 
70]. Given that hOGG1 expression is significantly related to HCC carcinogenesis [71, 72], 
Peng et al. [68] explored the effects of hOGG1 rs1052133 polymorphism on 8-oxyG levels and hOGG1 expression in Guangxiese population with AFB1 exposure. They observed that 
Cys alleles downregulated hOGG1 expression and increased 8-oxyG levels. These findings suggested the pathogenic role of hOGG1 Cys326Ser polymorphism in the carcinogenesis of 
AFB1-related HCC.
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Figure 3. The base excision repair for oxidative DNA damage 8-oxyG in mammalian cells. In this repair pathway, human 
8-oxoguanine DNA glycosylase (hOGG1) can catalyze the release of 8-oxyG (Red) and the cleavage of DNA at the AP site.
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7. The XRCC1 GSNPs and AFB1-HCC among Guangxiese population
X-ray repair cross-complementing group 1 (XRCC1), also called RCC, spans about 32 kb on 
chromosome 19q13.2 and contains 17 exons and 16 introns. The encoding protein of XRCC1 
acts as a scaffold protein in SSBR and BER pathways via the interaction with Pol β, DNA 
ligase III, and PARP [73]. According to data from SNP database, more than 50 GSNPs in the 
coding region of XRCC1 gene, which lead to amino acid substitution, have been identified. Of 
GSNPs, rs25487 polymorphism (at codon 399, Arg → Gln) is of special concern, because this 
GSNP resides in functionally significant regions and may decrease DNA repair activity and 
increase the risk of gene mutation cancers [3].
In Guangxi area, a total of five molecular epidemiological studies were found in PubMed 
Database, Web of Science Database, Wangfang Database, Google Database, and Weipu 
database (Table 3). In 2005, Long et al. [74] investigated the effects of XRCC1 rs25487 poly-
morphism on AFB1-related HCC risk. In their study, they included 140 patients with patho-
logically diagnosed HCC and 536 age-, sex-, race-, and hepatitis virus-matching controls 
and found significantly different distribution of three genotypes of XRCC1 rs25487 poly-
morphism (Arg/Arg, Arg/Gln, and Gln/Gln) between cases and controls (51.43, 45.00, and 
3.57% for patients with HCC, 6.54, 29.66, and 2.88% for controls). Regression logistic analy-
sis shows that mutant alleles of this polymorphism increase AFB1-related HCC risk (OR = 
2.18, 95% CI = 1.27–3.74). They also observed more noticeable risk role for HCC under the 
conditions of individuals with both high AFB1 exposure and mutant genotypes of XRCC1 
rs25487 polymorphism (risk value 1.84–10.87). The several following molecular epidemio-
logical studies furthermore prove these results [49, 75, 77]. However, associations between 
No. Ref. Year AFB1 
exposurea
Methods Matching 
factor
Cases (n) Controls (n) Risk valueb 
(OR)
1 Long et al. [74] 2005 High Case-
control
Age, sex, 
HBV, HCV, 
race
140 536 2.18  
(P = 0.0001)
2 Long et al. [75] 2006 High Case-
control
Age, sex, 
HBV, HCV, 
race
257 649 2.47  
(P = 0.0001)
3 Zeng et al. [76] 2010 High Case-
control
No 500 507 about 1  
(P > 0.05)
4 He et al. [77] 2012 High Case-
control
Age, sex 119 119 2.50  
(P < 0.05)
5 Yao et al. [49] 2014 High Case-
control
Age, sex, 
HBV, HCV, 
race
1486 1996 2.19–4.27  
(P < 0.001)
Notes: a Defined by means of Henry et al. (Science, 1999, 286: 2453-2454).
b AFB1-related HCC risk will increase if OR > 1 and corresponding P-value < 0.05; will decrease if OR < 1 and 
corresponding P-value < 0.05; and will not change if OR is about 1 and/or corresponding P-value > 0.05.
Table 3. Characteristics of studies about genetic polymorphism at codon 399 of XRCC1 and AFB1-related HCC risk.
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XRCC1 rs25487 polymorphism and individual susceptibility to HCC have been reported in 
a case-control study with the insignificant results [76]. This may be because of nonmatch-
ing design and the effects of confounders such as age, gender, race, and hepatitis viruses. 
Supporting aforementioned conclusions, meta-analysis from data in high AFB1 exposure 
areas also exhibited that these subjects with Gln alleles of XRCC1 rs25487 polymorphism had 
increasing HCC risk (OR > 1, P < 0.01) [78]. This suggests that XRCC1 rs25487 polymorphism 
should be a risk biomarker of Guangxiese HCC related to AFB1 exposure.
8. The XRCC3 GSNPs and AFB1-HCC among Guangxiese population
X-ray repair cross-complementing group 3 (XRCC3) is an important paralogs of the strand-
exchange protein RAD51 and is primarily found and cloned by functional complementa-
tion in the Chinese hamster cell line irs1SF. This gene spans about 17.8 kb on chromosome 
14q32.33 and contains 10 exons. Functionally, XRCC3 can bind directly with DNA breaks and 
facilitate the formation of the RAD51 nucleoprotein filament and protein-protein interaction 
of RAD51 family members in the SSBR pathway [79]. In XRCC3-defective irs1SF hamster 
cells, spontaneous chromosomal aberrations, high sensitivity to cross-linking agents, mild 
sensitivity to gamma rays, and significantly attenuated Rad51 focus formation after gamma 
ray exposure were observed, which suggests that XRCC3 is crucial for the SSBR pathway [80].
Recent molecular epidemiological studies have shown that the function of XRCC3 is modified 
by its GSNPs. Of the known GSNPs, only rs2228001 polymorphism (at codon 241, Thr → Met) 
is of special concern, because this GSNP results the change Thr to Met at codon 241 [81–83]. Up 
to now, three reports from high AFB1-exposure areas of Guangxi supported the above-men-
tioned conclusions [49, 84, 85]. In the first frequent case-control study in Guangxi population 
[85], higher mutant frequencies at codon 241 of XRCC3 are observed among cases with HCC 
than controls (33.01 vs. 61.48%, P < 0.001). The results from logistic regression analysis further 
prove that this mutate increases about 2- to 10-time risk of HCC. The following two relatively 
larger sample size molecular epidemiological studies (study 1 conducted by Long et al. [84] 
consisting of 491 patients with HCC and 862 healthy controls; study 2 from Yao et al. [49] 
including 1486 cases and 1996 controls) were accomplished in high AFB1 exposure. Similar to 
data from the first study, individuals having the mutant genotypes of XRCC3 rs2228001 poly-
morphism would feature higher risk of developing HCC. Interactive analysis of risk genotypes 
and AFB1 exposure further demonstrated that this allele multiplicatively interacted with AFB1 
exposure in the process of hepatotumorigenesis [49]. Taken together, these results suggest that 
the GSNPs in XRCC3 gene, such as rs2228001 polymorphism, might a genetic determinant in 
the HCC carcinogenesis caused by AFB1 exposure among Guangxiese population.
9. The XRCC7 GSNPs and AFB1-HCC among Guangxiese population
X-ray repair cross-complementing 7 (XRCC7), also called protein kinase DNA-activated cata-
lytic polypeptide (PRKDC), spans about 197 kb on 8q11.21 and contains 85 exons. Protein 
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encoded by his gene is a member of the PI3/PI4-kinase family and acts as the catalytic subunit 
of the DNA-dependent protein kinase (DNA-PK). Functionally, it interacts with the Ku70/
Ku80 heterodimer protein in the nonhomologous end joining (NHEJ) repair and recombina-
tion [86–88]. More than 200 of GSNPs have been reported in the XRCC7 gene, some of which are 
reported to affect tumorigenesis of malignant tumors [89–93]. In Guangxi area, several reports 
imply XRCC7 rs7003908 polymorphism (T to G) may be associated with HCC related to AFB1 
exposure [49, 94]. Through a hospital-based case-control study (including 348 cases with HCC 
and 597 age-, gender-, race-, and hepatitis viruses-matched healthy controls) conducted in 
high AFB1 exposure area from Guangxi, Long et al. [94] investigated the association between 
XRCC7 rs7003908 polymorphism and HCC risk and found significantly different distribution 
of three genotypes (rs7003908-TT, -TG, and -GG) between cases and controls (25.9, 44.5, and 
29.6% for patients with HCC, 58.1, 30.0, and 11.9% for controls). Regression logistic analysis 
shows that mutant alleles of this polymorphism increase AFB1-related HCC risk, with risk 
value of 3.45 (2.40–4.94) for rs7003908-TG and 5.04 (3.28–7.76) for rs7003908-GG, respectively. 
Furthermore, this GSNP was also related to higher the amounts of DNA adducts induced by 
AFB1 (r = 0.142) [94]. Interestingly, it also multiplicatively interacts with AFB1-exposure vari-
able (interactive value: OR = 1.74; 95% CI = 1.66–1.82; P = 2.21 × 10−133) [49]. Taken together, these 
data exhibited that the XRCC7 rs7003908 polymorphism might modify AFB1-related HCC risk 
via decreasing NHEJ capacity. However, more studies are inquired to support this conclusion.
10. The XRCC4 GSNPs and AFB1-HCC among Guangxiese population
X-ray repair cross-complementing 4 (XRCC4, also known as SSMED) is an important NHEJ 
pathway gene locating on 5q14.2 and spanning about 293 kb. This gene is a generally expressed 
protein of 334 amino acids residues and functions together with DNA ligase IV and DNA-PK 
in the repair of DNA double-strand breaks. XRCC4 plays an important role in both nonho-
mologous end joining and the completion of V(D)J recombination [95, 96]. Increasing evidence 
has shown that mutations in XRCC4 can cause short stature, microcephaly, and endocrine 
dysfunction (SSMED) resulting from more-deficient NHEJ capacity [97, 98]. This suggests 
that the low repair capacity of this gene from genetic changes might be associated with cancer 
risk [99, 100]. Up to now, only two GSPs in the XRCC4 gene, namely, rs28383151 (at codon 
56, Ala to Thr) and rs3734091 (at codon 247, Ala to Ser), have reported to be correlated with 
risk of AFB1-related HCC among Guangxiese population [13, 14, 49]. In these studies, Long 
et al. [13, 14] have examined the association between genetic polymorphisms (Ala56Thr and 
Ala247Ser) in XRCC4 and risk of HCC in a large case-control study in at-risk Guangxiese 
population. Genotypes were determined in 1499 patients with HCC and 2045 individually 
matched controls. We observed that individuals with Thr/Thr genotype at Arg194Trp site and 
Ser/Ser genotype at Ala247Ser site of XRCC4 had about twofold and threefold increased risk 
for the cancer compared with wild types, respectively. Furthermore, when risk genotypes 
of XRCC4 and AFB1-exposure were combined, this risk role was more noticeable, with the 
adjusted OR being11.26 (95% CI, 8.36–15.18) for rs28383151 polymorphism and 14.43 (95% CI, 
7.98–26.09) for rs3734091 polymorphism, respectively. Interactive analysis further exhibited 
this multiplicative interaction (interactive OR = 1.64, 95% CI = 1.55–1.73, 6.41 × 10−73) [49]. 
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Functional exploration showed that these two polymorphisms increased AFB1-DNA adducts 
levels and TP53M risk, and AFB1-related HCC prognosis, suggesting they should be impor-
tant modified factors of AFB1 toxicological effects [5, 13, 14]. Together, these results imply that 
XRCC4 rs28383151 and rs3734091 polymorphisms might play a role in the carcinogenesis of 
the liver under the conditions of AFB1 exposure.
11. Future directions
In the past decades, great progress has been made in understanding the molecular mecha-
nisms of the GSNPs affecting risk of AFB1-related HCC. However, we are still far from a 
comprehensive view of this effect. The molecular mechanism about GSNPs in the DNA repair 
genes modifying the risk of HCC caused by AFB1 remains largely unknown. Although sev-
eral reports have displayed that GSNPs may progress tumorigenesis of AFB1-related HCC 
via downregulating expression of DNA repair genes, breaking the structure of DNA repair 
proteins, or decreasing the function of DNA repair genes, more direct evidence is still miss-
ing. Disclosing the roles of different phenotypes of DNA repair genes will greatly benefit our 
understanding of pathological mechanisms of GSNPs affecting AFB1-related HCC risk, and 
will shed important light on the prevention values for individuals with risk types.
12. Conclusion
Like most other human cancers, HCC is a complex disease attributed to environment varia-
tion and genetic susceptive factors. In high incidence areas of HCC in Guangxi, AFB1 is an 
important environment variation. In the process of AFB1 hepatocarcinogenesis, DNA dam-
age induced by AFB1 exposure plays a central role because of their genotoxicity and inter-
actions with genetic susceptive factors. Numerous studies reviewed in this chapter have 
demonstrated that the hereditary variations in DNA repair genes (including XRCC1, XRCC3, 
XRCC4, XRCC7, hOGG1, XPC, and XPD) are related to the susceptibility to AFB1-related 
HCC among Chinese population. These molecular epidemiological studies have significantly 
contributed to our knowledge of the importance of genetic polymorphisms in DNA repair 
genes in the etiology of HCC related to AFB1 exposure. It would be expected that genetic sus-
ceptibility factors involved in DNA repair genes for HCC could serve as useful biomarkers for 
identifying at-risk individuals and, therefore, targeting prevention of this malignant tumor.
However, there are several issues to be noted. Because of conflicting data existing in the same 
ethnic population in view of between some genotypes of DNA repair genes and the risk of 
HCC related to AFB1, the conclusions should first be drawn carefully. For example, whether 
the XRCC1 Arg399Gln polymorphism is a risk factor or not remains controversial and further 
studies are needed. Second, because of the difference in population frequencies corresponding 
to genetic polymorphisms that depend on ethnicity, caution should be taken, particularly in 
extrapolating these data to other ethnic populations, especially from other high AFB1-exposure 
areas. Third, when risk of a specific polymorphism is considered, AFB1 exposure should be 
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stressed because AFB1 exposure may differ from areas to areas and from individuals to indi-
viduals. Last, in view of that fact the development of AFB1-related HCC is “polygenic,” a 
panel of susceptive biomarkers are warranted to define individuals at high risk for this cancer.
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